Idiosyncratic reactions to drugs: Can medicine response profiles provide a dynamic drug surveillance system?

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 9, 2000, Pages 815-818

  Roses, A D ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Adverse events; Pharmacogenetics; Safety; Single nucleotide polymorphisms; Surveillance

Indexed keywords

APOLIPOPROTEIN C1; APOLIPOPROTEIN E4; DNA; DRUG;

ADVERSE DRUG REACTION; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 19; CONTROLLED STUDY; DRUG RESPONSE; DRUG SURVEILLANCE PROGRAM; GENE LINKAGE DISEQUILIBRIUM; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFORMATION PROCESSING; MIGRAINE; PHARMACOGENETICS; PHENOTYPE; POSTMARKETING SURVEILLANCE; PREDICTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0033760287     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.117     Document Type: Article

References (6)

1. Making medicines safer-the need for an independent drug safety board
2. Pharmacogenetics and future drug development and delivery
3. Pharmacogenetics and the practice of medicine
4. SNPing away at complex diseases: Analysis of single-nucleotide polymorphisms around APOE in Alzheimer Disease
5. A 4-Mb high-density single nucleotide polymorphism-based map around human APOE
6. The use of single-nucleotide polymorphisms maps in pharmacogenomics